Revenues aren’t healthy enough, Aveanna Healthcare falls 2% on fiscal 2026 guidance miss

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) reported fourth quarter results that exceeded analyst expectations, but shares declined 2.3% as the company’s fiscal 2026 guidance fell short of Wall Street estimates.

The home care provider posted fourth quarter adjusted EPS of $0.17, beating the analyst consensus of $0.13 by $0.04. Revenue reached $662.5 million, surpassing the estimate of $630.6 million and representing a 27.4% increase YoY from $519.9 million in the prior year period. The revenue growth was driven by increases across all three operating divisions, with the PDS segment contributing $118.5 million of the overall increase.

The company maintained its full year 2026 revenue guidance of $2.54 billion to $2.56 billion. The midpoint of $2.55 billion falls below the analyst consensus of $2.56 billion. The company also maintained its adjusted EBITDA guidance of $318 million to $322 million for fiscal 2026.

Adjusted EBITDA for the fourth quarter was $85.0 million, or 12.8% of revenue, representing a 54.0% increase from $55.2 million in the prior year period. Net income was $178.8 million compared to $29.2 million in the fourth quarter of fiscal 2024.

“Fourth quarter results are headlined by revenue and adjusted EBITDA growth of 27.4% and 54.0%, respectively, when compared to the prior year period,” said Jeff Shaner, Chief Executive Officer. “With the integration of Thrive Skilled Pediatric Care completed, we are well-positioned for further acquisition activity, including the recently announced Family First Homecare transaction.”